| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |